These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26094796)

  • 1. Progress in visual representations of chemical space.
    Osolodkin DI; Radchenko EV; Orlov AA; Voronkov AE; Palyulin VA; Zefirov NS
    Expert Opin Drug Discov; 2015; 10(9):959-73. PubMed ID: 26094796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches for enhancing the analysis of chemical space for drug discovery.
    Saldívar-González FI; Medina-Franco JL
    Expert Opin Drug Discov; 2022 Jul; 17(7):789-798. PubMed ID: 35640229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity landscape of DNA methyltransferase inhibitors bridges chemoinformatics with epigenetic drug discovery.
    Naveja JJ; Medina-Franco JL
    Expert Opin Drug Discov; 2015 Oct; 10(10):1059-70. PubMed ID: 26289576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery.
    Reutlinger M; Schneider G
    J Mol Graph Model; 2012 Apr; 34():108-17. PubMed ID: 22326864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generative Topographic Mapping (GTM): Universal Tool for Data Visualization, Structure-Activity Modeling and Dataset Comparison.
    Kireeva N; Baskin II; Gaspar HA; Horvath D; Marcou G; Varnek A
    Mol Inform; 2012 Apr; 31(3-4):301-12. PubMed ID: 27477099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual characterization and diversity quantification of chemical libraries: 1. creation of delimited reference chemical subspaces.
    Le Guilloux V; Colliandre L; Bourg S; Guénegou G; Dubois-Chevalier J; Morin-Allory L
    J Chem Inf Model; 2011 Aug; 51(8):1762-74. PubMed ID: 21761916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of activity landscapes for drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoinformatics and library design.
    Zhou JZ
    Methods Mol Biol; 2011; 685():27-52. PubMed ID: 20981517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversifying chemical libraries with generative topographic mapping.
    Lin A; Beck B; Horvath D; Marcou G; Varnek A
    J Comput Aided Mol Des; 2020 Jul; 34(7):805-815. PubMed ID: 31407224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generative topographic mapping in drug design.
    Horvath D; Marcou G; Varnek A
    Drug Discov Today Technol; 2019 Dec; 32-33():99-107. PubMed ID: 33386101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of molecular fingerprints.
    Owen JR; Nabney IT; Medina-Franco JL; López-Vallejo F
    J Chem Inf Model; 2011 Jul; 51(7):1552-63. PubMed ID: 21696145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stargate GTM: Bridging Descriptor and Activity Spaces.
    Gaspar HA; Baskin II; Marcou G; Horvath D; Varnek A
    J Chem Inf Model; 2015 Nov; 55(11):2403-10. PubMed ID: 26458083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaching for the bright StARs in chemical space.
    Medina-Franco JL; Naveja JJ; López-López E
    Drug Discov Today; 2019 Nov; 24(11):2162-2169. PubMed ID: 31557448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a three-dimensional multitarget activity landscape.
    de la Vega de León A; Bajorath J
    J Chem Inf Model; 2012 Nov; 52(11):2876-83. PubMed ID: 23113585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mappability of drug-like space: towards a polypharmacologically competent map of drug-relevant compounds.
    Sidorov P; Gaspar H; Marcou G; Varnek A; Horvath D
    J Comput Aided Mol Des; 2015 Dec; 29(12):1087-108. PubMed ID: 26564142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graph mining: procedure, application to drug discovery and recent advances.
    Takigawa I; Mamitsuka H
    Drug Discov Today; 2013 Jan; 18(1-2):50-7. PubMed ID: 22889967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the Visualization and Mining of Chemical and Target Spaces.
    Medina-Franco JL; Aguayo-Ortiz R
    Mol Inform; 2013 Dec; 32(11-12):942-53. PubMed ID: 27481140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Representation of multi-target activity landscapes through target pair-based compound encoding in self-organizing maps.
    Iyer P; Bajorath J
    Chem Biol Drug Des; 2011 Nov; 78(5):778-86. PubMed ID: 21895984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.